An exploratory subanalysis on the impact of EPO levels on mortality was performed in patients without and with anemia, as well as in patients with normal (CKD 1+2) and moderately impaired renal function (CKD 3) (see Figure 3). This evidence concerns the gene EPO and anemia (phenotype).